Cytek Biosciences, Inc. (NASDAQ:CTKB) is a favorite amongst institutional investors who own 51%

By Yahoo! Finance | Jul 22, 2024 at 09:57 AM EST

Ownership research and analyst forecasts provide insights into stock opportunities. Institutional investors own 51% of Cytek Biosciences, impacting its market moves. Top shareholders include BlackRock, Brown Capital Management, and The Vanguard Group. Insider ownership and public and private equity stakes also influence company decisions.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.